Social media

For the second article in our new series, we delve deeper into ISO 14971 (Application of risk management to medical devices). We discuss a history of risk-based thinking and common misunderstandings around risk analysis ...

What happens after your JCA submission? Discover how different EU countries integrate JCA findings into local pricing and reimbursement decisions - and how to prepare. Explore the full guide: https://ow.ly/YURE50XgHt1 #...

When asked what matters most, patients living with obesity ranked self-esteem, energy, social participation, and body image above all else. How can sponsors design trials that truly reflect those priorities? Learn more i...

Join ICON at booth #8 during the #OCTDACH conference, taking place 12–13 November at the Kameha Grand in Zurich, Switzerland. As a trusted partner to biotech and pharmaceutical companies across the DACH region, ICON del...

Join ICON at booth \#8 during the #OCTDACH conference, taking place 12–13 November at the Kameha Grand in Zurich, Switzerland. As a trusted partner to biotech and pharmaceutical companies across the DACH region, ICON de...

Attending #ObesityWeek on Nov 4–7? Meet us as booth \#520 to learn how our comprehensive lab and imaging capabilities support high-quality, large-scale obesity studies. From AI-driven imaging biomarkers to expert guidanc...

ICON is pleased to announce its participation in the PHUSE Single Day Event taking place on 7 November in Bloemfontein, South Africa. The event will bring together professionals from across the clinical data science comm...

Clinical trials generate more data than ever. ICON’s new blog reveals how technology—from central monitoring to predictive analytics—makes risk-based quality management more agile, efficient and focused. Discover how sma...

At ICON, career growth is built on curiosity, drive, and determination. Christopher Maguire, Director of Finance Business Partnering, has progressed through six roles in eight years, with each role offering new challen...

ICON is proud to be at ISPOR Europe 2025 in Glasgow. Let’s talk about: - Health economics & outcomes research - Real-world evidence - Patient-centred value strategies Together, we can power value and access in healthca...

In this new blog series, we review ISO 14971 (Application of risk management to medical devices) - its history, the principles embedded within it and how it relates to other standards and regulation. For the first editio...

Meet ICON experts at the AASLD to learn how ICON partners with sponsors, investigators, patients and other collaborators to deliver strategic, data-driven solutions for MASH and hepatology studies. https://ow.ly/9QBn50X8...